Trials / Terminated
TerminatedNCT03107390
Evaluation of NT-proBNP in Chronic Inflammatory Bowel Disease
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 159 (actual)
- Sponsor
- Centre Hospitalier Universitaire, Amiens · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
NT-proBNP is a major diagnostic and prognostic marker in cardiology, but it is also a new marker for biological inflammation, especially in rheumatology. Its evaluation in chronic inflammatory bowel disease was carried out in a preliminary study, the OPERA study where in a population of 12 patients showed an increase in NT-proBNP correlated with the biological and endoscopic activity of the disease. This larger study is therefore a pilot study that could see NTproBNP as a new biomarker of inflammation in MICI.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Evaluate the blood level of NTproBNP | Evaluate the blood level of NTproBNP in patients with MICI compared to a healthy control population. |
Timeline
- Start date
- 2013-10-28
- Primary completion
- 2017-08-07
- Completion
- 2017-08-07
- First posted
- 2017-04-11
- Last updated
- 2020-07-15
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03107390. Inclusion in this directory is not an endorsement.